To The Moon

$Novavax(NVAX)$60

$Novavax(NVAX)$Bearish deserves Jim Cramer's House of Pain! 💉The target is Sell sell sell sell sell... Is that enough sells? Please someone tell NVAX they are two years late. [Cry] It all started so beautifully.The U.S. government invested $1.6 billion in Novavax in 2020 — the most for any vaccine maker at the time — in hopes that it would offer an alternative for a safe and effective Covid vaccine.Novavax's protein technology differentiated itself from $Pfizer(PFE)$ and $Moderna, Inc.(MRNA)$ messenger-RNA-based Covid shots, so what happened? Answers, I want answers!- Generally, each vaccine batch should reach at least

Summary why it dropped $Novavax(NVAX)$It Sees a Shortfall in Demand for Covid-19 Vaccines. Novavax slumped more than 31% Tuesday after the Covid-19 vaccine maker slashed its guidance for 2022 revenue.they said it expects revenue this year of $2 billion to $2.3 billion, down from previous expectations of $4 billion to $5 billion. my opinion ; They're about two years late to the party and now nobody cares about Covid anymore. All a hoax just like the flu shot designed to line the pockets of drug companies.If u were to see the options with 30% buffer with2% premium so it's a dangerous buy 

I would give $Novavax(NVAX)$a miss, as I prefer established pharmaceutical companie with a line of cash cows from approved drugs proven to treat common diseases and a long pipeline of drugs in various stages of clinical trials.Examples of my preference are $Pfizer(PFE)$and $Merck(MRK)$that do not rely on a single drug for profitability, and whose earnings are stable. This is unlike Novavax which depends on the success of its COVID-19 vaccine and whose share price is highly volatile due to the high dependency on a single drug. This is not helped by the lateness of its COVID-19 vaccine, that falls far behind those of Pfize

$Novavax(NVAX)$Bearish on Novovax as they cut their revenue expectations by half. 50% is no small matter.Aside, clinically, Pfizer and Moderna are muchfaster ahead with their omicron vaccines and Novovax has yet to prove itself to be better than mRNA technology.On the numbers front, the valuation looks horrible with negative ROE, EBIT per share, ROIC, operative margin trends. Based on PB, a 48 ratio sounds insane.I am not certain about the MOAT of this company and hence will not attempt any sensible valuation.My advise will be to STAY AWAY.What do you think? Let me know if you have some valuable insights for Novovax.Aside, some of you will be facing situations like this right now. Oh ya did I mention there's a new virus f

$39.50 TP

Bear has arrived. Caution is necessary.

Novavax crushed yesterday Novavax (NVAX) $Novavax(NVAX)$ slashed its 2022 outlook on tumbling demand for Covid vaccines, leading NVAX stock to crash Tuesday.The decision followed a major second-quarter disappointment in which sales came in at less than one-fifth what analysts projected. Further, Novavax reported an unexpected loss that widened vs. last year's second quarter. Wall Street had expected Novavax to tack on a second straight quarter of gains.On today's stock market, NVAX stock plummeted 29.6% to close at 40.28."Novavax adjusted guidance for 2022 to account for several evolving market dynamics," the company said in a written statement. "We remain confident in our vaccine as a strong additional choice. Its c

$Novavax(NVAX)$Up!

[Call] [Call] [Call] [Call] [Call] [Call] [Call] [Call] 

buy100000

$Novavax(NVAX)$$70  easily in next 2 months! 

Novavax is a 💔💔💔-Elsa sings, "Let it go,let it go, can't hold it back anymore 🎈🎈🎈" $Novavax(NVAX)$NVAX has been a heartache to a lot of investors 💔💔💔 It tumbled from its all-time high of USD 319.93 on Feb 8, 2021, which is a about an 88% CRASH 😱😱😱NVAX has repeatedly pushed back production forecasts & has struggled to access raw materials & equipment needed to make its vaccine 🗓🏭 💉Till now…NVAX still hasn’t obtained full FDA approval for its vaccine ❌ It was only granted Emergency Use Authorisation for over 18 year-olds in early June & WHO has not recognised their vaccine use for below 18 years of age ❌Now, it has even:(1) posted a 3rd quarter loss of 6.53 per share, with revenues slowing 37.6% from last y

$Novavax(NVAX)$ttarget price $29

$Novavax(NVAX)$price correction needed. Because the price shd be lower than that of Pfizer given the difference in profit scale. $20 is a decent pricing 

$诺瓦瓦克斯医药(NVAX)$add only when it drop to the price before Covid, that is, below 10

What a joke of a company. Had so much potential that fizzled under a poor mgt

35 usd

$Novavax(NVAX)$Time to dump thisstock into waste bin.  Poor leadership that lead to its downfall despite a good product. 

$Novavax(NVAX)$This is the worst stock ever good news increase abit now bad news drop ever further useless CEO